高场强术中MRI提高无功能垂体腺瘤切除率并延长无进展生存期
该回顾性研究纳入133例接受内镜经蝶手术的无功能垂体腺瘤患者,使用1.5T术中MRI。术中MRI使全切除率从42.9%提高至63.9%,全切除患者肿瘤复发率更低,肿瘤残留是肿瘤进展的影响因素。
要点
- 术中MRI使无功能垂体腺瘤全切除率从42.9%升至63.9%
- 全切除患者肿瘤复发率低于未全切除者
- 肿瘤残留是肿瘤进展的影响因素
核心结论
- 高场强术中MRI可提高内镜经蝶手术治疗无功能垂体腺瘤的全切除率,全切除率提高与更长的无进展生存期相关。
研究设计与样本
- 回顾性分析133例连续接受内镜经蝶手术并使用1.5T术中MRI的无功能垂体腺瘤患者数据,平均随访62±9.4个月。
主要发现
- 比较首次和最终术中MRI扫描,全切除率从42.9%提高至63.9%。
- 随访期间8个肿瘤(9.4%)复发,29个残留(60.4%)再生,复发率和再生率分别为0.019和0.121患者/年。
- Kaplan-Meier分析显示全切除患者肿瘤复发率低于未全切除者(P < 0.01)。
- 单因素Cox回归分析提示肿瘤残留与肿瘤进展相关(风险比1.546;95%CI 1.071-2.232;P = 0.02)。
- 多因素logistic回归分析显示较低全切除率与较高Knosp评分(OR 3.612;95%CI 1.568-8.321;P = 0.003)、较大肿瘤体积(OR 0.926;95%CI 0.866-0.991;P = 0.025)和手术史(OR 0.376;95%CI 0.155-0.917;P = 0.031)相关。
临床怎么用
- 对于无功能垂体腺瘤的内镜经蝶手术,可考虑使用高场强术中MRI以指导手术切除,提高全切除率。
- 海绵窦侵袭、肿瘤体积较大和有手术史的患者全切除可能性较低,应予以关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of intraoperative magnetic resonance imaging (iMRI) on tumor control during endoscopic transsphenoidal surgery (TSS) for nonfunctioning pituitary adenomas (NFPAs) has not yet been completely characterized. The present study assessed the effect of the iMRI findings on gross total resection (GTR) and progression-free survival at a mean follow-up of 62 ± 9.4 months. METHODS: Retrospective analyses were performed on the data from 133 consecutive patients with NFPA who had undergone endoscopic TSS with iMRI using a 1.5T scanner. RESULTS: Compared with the first and final iMRI scans, the GTR rate increased from 42.9% to 63.9%. Multivariate logistic regression analysis revealed that a lower GTR rate was associated with a higher Knosp score (odds ratio [OR], 3.612; 95% confidence interval [CI], 1.568-8.321; P = 0.003), an increased tumor volume (OR, 0.926; 95% CI, 0.866-0.991; P = 0.025), and a history of surgery (OR, 0.376; 95% CI, 0.155-0.917; P = 0.031). During follow-up, 8 tumors (9.4%) recurred, and 29 remnants (60.4%) regenerated. The recurrence and regeneration rates were 0.019 and 0.121 patient/year, respectively. Kaplan-Meier analysis revealed that the tumor recurrence rates were lower for patients who had undergone GTR (P < 0.01) compared with those who had not. Univariate Cox regression analysis suggested that the presence of tumor remnants (hazard ratio, 1.546; 95% CI, 1.071-2.232; P = 0.02) was the influencing factor associated with tumor progression. CONCLUSIONS: High-field iMRI can increase the GTR rate in endoscopic TSS for NPFAs. The increased GTR rate was associated with longer progression-free survival. Cavernous sinus invasion, tumor size, and surgical history were important predictors of GTR in patients with NFPA.
引用
- Zhang Z, Yang K, Xia Y, et al. High-Field Intraoperative Magnetic Resonance Imaging Increases Extent of Resection and Progression-Free Survival for Nonfunctioning Pituitary Adenomas. World Neurosurg. 2019. PMID: 30974275. doi:10.1016/j.wneu.2019.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。